4//SEC Filing
Zeskind Benjamin J. 4
Accession 0001415889-22-012975
CIK 0001790340other
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 8:14 AM ET
Size
7.6 KB
Accession
0001415889-22-012975
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Zeskind Benjamin J.
DirectorPRESIDENT AND CEO10% Owner
Transactions
- Exercise/Conversion
Class A Common Stock
2022-12-22$3.01/sh+2,500$7,525→ 2,261,852 total - Exercise/Conversion
Stock Option
2022-12-22−2,500→ 203,500 totalExercise: $3.01Exp: 2029-12-15→ Class A Common Stock (2,500 underlying)
Holdings
- 894,927(indirect: See Foonote)
Class A Common Stock
Footnotes (2)
- [F1]Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee.
- [F2]The option has fully vested and is currently exercisable.
Documents
Issuer
Immuneering Corp
CIK 0001790340
Entity typeother
Related Parties
1- filerCIK 0001870062
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 8:14 AM ET
- Size
- 7.6 KB